Sosei planning IPO

Drug development and reprofiling company Sosei (Tokyo, Japan) plans to raise 10.2 billion Yen ($95.3 million) in an IPO on the Tokyo Stock Exchange's market of the high-growth and emerging stocks (MOTHERS). Sosei expects its post-money valuation will be 50.4 billion Yen ($471 million). Underwriters on the deal are Nomura; Merrill Lynch; and Daiwa Securities SMBC. Trading is expected to start on July 29. ...